Kymera Therap 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
SAR444656 / Sanofi
ADVANTA, NCT06058156: Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic Dermatitis

Recruiting
2
200
Europe, US
SAR444656 (KT-474), Placebo
Sanofi, Kymera Therapeutics, Inc.
Atopic Dermatitis
07/26
08/26
ZEN, NCT06028230: A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

Recruiting
2
156
Europe, US
SAR444656 (KT-474), Placebo
Sanofi, Kymera Therapeutics, Inc.
Hidradenitis Suppurativa
06/26
07/26
KT-413 / Kymera Therap
NCT05233033: Safety, PK/PD, and Clinical Activity of KT-413 in Adult Patients with Relapsed or Refractory B-cell NHL

Completed
1
7
Europe, US
KT-413
Kymera Therapeutics, Inc.
Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, DLBCL, MYD88 Gene Mutation
07/23
07/23
KT-333 / Kymera Therap
KT333-TL-101, NCT05225584: Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients with Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors

Active, not recruiting
1
120
US
KT-333
Kymera Therapeutics, Inc.
Non Hodgkin Lymphoma (NHL), Peripheral T-cell Lymphoma (PTCL), Cutaneous T-Cell Lymphoma (CTCL), Large Granular Lymphocytic Leukemia (LGL-L), T-cell Prolymphocytic Leukemia (T-PLL), Solid Tumors
02/25
03/25
KT-253 / Kymera Therap
KT253-AL-101, NCT05775406: Safety and Clinical Activity of KT-253 in Adult Patients with High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid Tumors

Completed
1
52
US
KT-253
Kymera Therapeutics, Inc.
Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphomas, Advanced Solid Tumors
12/24
12/24
KTX-475 / Kymera Therap
No trials found
KTX-582 / Kymera Therap
No trials found

Download Options